Replay available

Caris Life Sciences, Inc. (CAI) Q3 2025 Earnings Call

Caris Life Sciences, Inc. (NASDAQ: CAI) Q3 2025 earnings conference call, held 2025-11-05. Replay captured from the company's public earnings webcast.

Wed, November 5, 2025 at 4:30 PMendedReplay
Caris Life Sciences, Inc. (CAI) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Jeff Cohn

Analyst, Ladenburg Thorndike

Walter Shanker

Analyst, Mazz Partners

Joshua Lev

Chief Financial Officer

Tom Errico

Chairman of the Board

Dan Goldberger

Chief Executive Officer

Jeremy Pearlman

Analyst, Maxim Group

Replay transcript excerpt

Thank you everyone for joining. The call will begin shortly. Greetings, everyone, and welcome to the Electric Core third quarter 2025 earnings conference call. At this time, all participants have been placed in a listen-only mode. Please make sure to mute yourself. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It's now my pleasure to introduce you to your host, Dan Goldberger, Electric Core's Chief Executive Officer. Dan. Thank you all for participating in today's ElectraCore earnings call. Joining me today are Dr. Thomas Arako, one of our founders and investor and our newly elected chairman, Joshua Lev, our chief financial officer, and our investor relations team from FNK IR. Earlier today, ElectraCore published results for the third quarter ended September 30th, 2025. A copy of the press release is available on the company's website. I'd like to remind you that management will make statements during the call that include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not statements of historical facts should be deemed to be forward-looking statements. All forward-looking statements, including without limitation any guidance, outlook, or future financial expectations or operational activities and performance, are based upon the company's current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue rel...

More from Caris Life Sciences, Inc.